Status:
COMPLETED
Study Evaluating Treatment Adherence in Patients Treated With Oral Targeted Therapy in Oncology Supported by a Dedicated and Coordinated Follow-up Compared to Standard Follow-up.
Lead Sponsor:
Institut Claudius Regaud
Conditions:
Metastatic Solid Tumor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective, comparative, open label, randomized, multicentric study evaluating the benefit of a dedicated and coordinated follow-up on treatment adherence in patients with metastatic solid ...
Eligibility Criteria
Inclusion
- Patient with a metastatic solid tumor and starting a first cycle of oral targeted therapy whatever the treatment line
- Age \> or = 18 years old
- Affiliated to the french social security system
- Patient must provide written informed consent prior to any study-specific procedure or assessment
Exclusion
- Patient not available by phone or with no caregiver who can answer the phone for him
- Pregnant or breastfeeding women
- Any psychological, familial, geographic or social situation, according to the judgment of investigator, potentially preventing the provision of informed consent or compliance to study procedure
- Patient protected by law
Key Trial Info
Start Date :
July 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 25 2022
Estimated Enrollment :
186 Patients enrolled
Trial Details
Trial ID
NCT03263416
Start Date
July 24 2017
End Date
January 25 2022
Last Update
January 31 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Claude Bernard
Albi, France, 81000
2
Centre Hospitalier Intercommunal Castres Mazamet
Castres, France, 81108
3
Clinique Des Cedres
Cornebarrieu, France
4
Institut Claudius Regaud
Toulouse, France, 31059